Logo image
Acute asthma exacerbations: phenotypes and management
Journal article   Peer reviewed

Acute asthma exacerbations: phenotypes and management

Charles B Cairns
Clinics in chest medicine, v 27(1), pp 99-108
01 Mar 2006
PMID: 16543055

Abstract

Adrenal Cortex Hormones - therapeutic use Adrenergic beta-Agonists - therapeutic use Anti-Asthmatic Agents - therapeutic use Asthma - diagnosis Asthma - genetics Asthma - therapy Humans Phenotype Severity of Illness Index
Acute asthma presentations account for 2 million emergency department visits annually in the United States. The causes for these presentations range from undertreated or unrecognized disease, to exacerbations of stable disease usually caused by recent exposure to triggers of exacerbations, to severe disease states unresponsive to conventional therapy. Indeed, many of these patients often exhibit both acute and chronic markers of severe asthma. The recognition of these phenotypes of acute asthma can enhance the management of these patients in acute and emergency settings. This article describes these potential phenotypes, reviews current therapies, and addresses the challenges of variability of therapeutic response in acute asthma.

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Respiratory System
Logo image